初级中枢神经系统淋巴瘤的新治疗策略
Adrien Gilbert1,2, Caroline Houillier2,3, Carole Soussain1,2,4
1Service d'Hématologie, Institut Curie, Saint-Cloud.
Current opinion in oncology
|August 5, 2025
概括
最近对初级中枢神经系统淋巴瘤 (PCNSL) 的治疗策略显示,通过密集整合,结果有所改善. 新的途径包括针对这种罕见的癌症的向治疗和免疫治疗.
科学领域:
- 神经瘤学神经瘤学
- 血液学 血液学 血液学
- 罕见的癌症 罕见的癌症
背景情况:
- 初级中枢神经系统淋巴瘤 (PCNSL) 是一种罕见且具有攻击性的恶性瘤.
- 目前的治疗策略在实现最佳反应率方面面临挑战.
研究的目的:
- 总结最近的PCNSL治疗策略.
- 探索这种罕见疾病的新兴治疗途径.
主要方法:
- 审查目前的诱导方案,包括高剂量甲状腺素 (HD-MTX).
- 评估巩固疗法,如自身干细胞移植.
- 评估维护策略和新的方法,如向治疗和免疫治疗.
主要成果:
- 基于高剂量甲状腺酸盐 (HD-MTX) 的疗法产生不够的反应率.
- 对于符合条件的患者来说,自主干细胞移植的密集整合是标准的.
- 由于神经毒性,传统的全脑放射治疗在很大程度上被放弃了.
- 嵌合式抗原受体T细胞的初步结果是有希望的.
- 细胞因子和循环瘤DNA显示出作为补充诊断工具的潜力.
结论:
- 密集整合改善了适合PCNSL患者的治疗结果.
- 未来的方向包括维护策略,向诱导,免疫疗法和先进的药物输送.
- 个性化,响应驱动的治疗需要风险分层和动态响应评估.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.9K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Primary Lymphoid Organs
6.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
6.1K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
